Why the study?
Does intravenous fluid therapy with bicarbonate and/or mannitol improve outcomes compared to intravenous fluid therapy alone in patients with rhabdomyolysis?
Does intravenous fluid therapy with bicarbonate and/or mannitol improve outcomes compared to intravenous fluid therapy alone in patients with rhabdomyolysis?
This systematic review highlights the lack of randomized controlled trials comparing intravenous fluid therapy alone versus with bicarbonate and/or mannitol for the treatment of rhabdomyolysis.
Answers are grounded in this paper and cite their sources.
No RCTs guide bicarbonate/mannitol use in rhabdomyolysis; leaves open whether they improve outcomes over fluids alone.
Most studies defined rhabdomyolysis based on creatine kinase values five times above the upper limit of normal. Etiologies differ among the adult and pediatric populations and no randomized controlled trials have been done to compare intravenous fluid therapy alone versus intravenous fluid therapy with bicarbonate and/or mannitol.
No takes yet. Share an insight, caveat, or question.
Chavez et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: